WELCOME TO JOHNS HOPKINS HEALTH ALERTS!

This free public service from Johns Hopkins Medicine helps keep you up to date on the latest breakthroughs for the most common medical conditions which prevent healthy aging. Browse all the articles via the Health Alert Topics navigation bar on the right, or read the headlines below.


Get the latest news sent straight to your Inbox. Register now for your FREE Johns Hopkins Health Alerts. Check the boxes below for all the topics you are interested in, enter your email address, and click "Send." It's fast, easy, and FREE.   Benefits of Being A Registered User

Enter your email here: (Example: yourname@domain.com)
Please send my alerts as:

We value your privacy and will never rent your email address.Already a Member? Manage your Health Alerts


Johns Hopkins Health Alert

Promising Therapies for Macular Edema

Comments (0)

Laser therapy, also called laser photocoagulation, is more effective and produces fewer side effects than corticosteroids injected into the eye for the treatment of diabetic macular edema according to a large, two-year multicenter study reported in the journal Ophthalmology (Volume 115, page 1447). Here’s what the study revealed.

Swelling around the macula (macular edema) caused by the leakage and accumulation of fluid can occur in people with diabetes. The swelling alters the position of the retina and causes blurred vision. Loss of vision is more pronounced when the center of the macula is affected.

Photocoagulation uses lasers to help close leaking microaneurysms (weak spots that bulge outward from the blood vessels), fostering the regression of new blood vessels. Laser photocoagulation helps to halt or slow vision loss in most people if it is performed before too much damage has occurred.

In the study, scientists randomly assigned 693 people (840 eyes) with diabetic macular edema to undergo laser treatment or to receive a 1- or 4-mg injection of triamcinolone (a corticosteroid) into the eye, each repeated at four-month intervals, as necessary, for two years.

At the first four-month check, vision was sharpest in those who had received a 4-mg injection of triamcinolone. At one year, vision was about the same in all three groups. But at two years, vision was significantly better in the laser treatment group. Of those who received laser therapy, 19% had substantial vision loss compared with 28% in the corticosteroid treated groups.

Cataract surgery was required in only 13% of eyes in the laser group compared with 23% in those who received 1 mg of triamcinolone and 51% in those who received 4 mg. Eye pressure increased by a significant amount in 4% of the laser group compared with 16% and 33% in the 1- and 4-mg corticosteroid groups, respectively.

Researchers are now studying combination therapy, since triamcinolone had better initial results and laser treatment was more effective over two years.

Posted in Diabetes on April 29, 2010
Reviewed January 2011


Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Johns Hopkins Health Alerts Disclaimer


Notify Me

Would you like us to inform you when we post new Diabetes Health Alerts?

Post a Comment

Comments

Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.

The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or Remedy Health Media, LLC, which has no responsibility for any comments posted on this site.


Post a Comment


Already a subscriber?

Login

Forgot your password?

New to Johns Hopkins Health Alerts?

Register to submit your comments.

(example: yourname@domain.com)

(800) 829-0422

Registered Users Log-in:

Forgot Password?

Become a Registered User!
It's fast and FREE!
The Benefits of Being a Registered User

Health Topic Pages

  • Health Alert
  • Special Report

What is this?

XML


Johns Hopkins’ Diabetes Bestsellers

Our Featured Title:

Johns Hopkins White Paper 2011: Diabetes


Related Titles: